InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the complete record of transactions filed by Levy Adam Scott, Chief Financial Officer. Director active across 1 companies, notably Mineralys Therapeutics, Inc.. In total, 6 filings have been logged. Total volume traded: €1.4m. The latest transaction was disclosed on 12 January 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
US$297,42910,758 shares@ US$27.64730.013% mcap41.2% of flow
Common Stock
SEC:0001693134-26-000002·
€297,42910,758 shares@ €27.64730.013% mcap20.6% of flow
Common Stock
SEC:0001693134-26-000002:0·
US$266,8417,366 shares@ US$36.2260.012% mcap37.0% of flow
Common Stock
SEC:0001933414-25-000130·
€266,8417,366 shares@ €36.2260.012% mcap18.5% of flow
Common Stock
SEC:0001933414-25-000130:0·
US$156,77112,946 shares@ US$12.10960.0069% mcap21.7% of flow
Common Stock
SEC:0001933414-25-000081·
€156,77112,946 shares@ €12.10960.0069% mcap10.9% of flow
Common Stock
SEC:0001933414-25-000081:0·
6 of 6 declarations
About Levy Adam Scott
Adam Scott Levy is the Chief Financial Officer and Secretary of Mineralys Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial reporting. His role is crucial in ensuring financial transparency and supporting Mineralys's growth strategy.
